CpG oligodeoxynucleotide developed to activate primate immune responses promotes antitumoral effects in combination with a neoantigen-based mRNA cancer …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development and …, 2021 - Taylor & Francis
Purpose The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …
被引用次数：22 相关文章

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development and …, 2021 - europepmc.org
Purpose The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development and …, 2021 - go.gale.com
Purpose: The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development and …, 2021 - dovepress.com
Purpose: The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …
[HTML] nih.gov

[HTML][HTML] CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development and …, 2021 - ncbi.nlm.nih.gov
Purpose The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …
[PDF] scienceopen.com

[PDF][PDF] CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA …

Q Li, J Ren, W Liu, G Jiang, R Hu - Drug Design, Development …, 2021 - scienceopen.com
Purpose: The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer …

Q Li, J Ren, W Liu, G Jiang… - Drug Design, Development …, 2021 - search.proquest.com
Purpose: The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer …

Q Li, J Ren, W Liu, G Jiang… - Drug design …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The purpose of our research was to identify and evaluate synthetic
phosphorothioate-modified CPG oligodeoxynucleotides (CPG-ODNs) activating innate and …